1 |
Aljunid S, Zafar A, Saperi S, et al (2010). Burden of disease associated with cervical cancer in malaysia and potential costs and consequences of HPV vaccination. Asian Pac J Cancer Prev, 11, 1551-9.
|
2 |
Best S, Niparko K, Pai S (2012). Biology of human papillomavirus infection and immune therapy for HPV-related head and neck cancers. Otolaryngol Clin North Am, 45, 807-22.
DOI
|
3 |
Alsaad M, Shamsuddin K, Fadzil F (2012). Knowledge towards HPV infection and HPV vaccines among Syrian mothers. Asian Pac J Cancer Prev, 13, 879-83.
DOI
ScienceOn
|
4 |
Babiker A, Eltom F, Abdalaziz A, et al (2013). Screening for high risk human papilloma virus subtypes, among Sudanese patients with oral lesions. Int J Clin Exp Med, 6, 275-81.
|
5 |
Barbieri D, Nocera M, Gallinella G, et al (2012). Comparison of HPV sign genotyping test with INNO-LiPA HPV genotyping extra assay on histologic and cytologic cervical specimens. Diagn Microbiol Infect Dis, 74, 43-8.
DOI
ScienceOn
|
6 |
Chimeddorj B, Pak C, Damdin A, et al (2008). Distribution of HPV-16 intratypic variants among women with cervical intraepithelial neoplasia and invasive cervical cancer in Mongolia. Asian Pac J Cancer Prev, 9, 563-8.
|
7 |
Chinchai T, Chansaenroj J, Junyangdikul P, et al (2011). Comparison between direct sequencing and INNO-LiPA methods for HPV detection and genotyping in Thai Women. Asian Pac J Cancer Prev, 12, 989-94.
|
8 |
Ciarrocca K, Jackson L, Rossi S (2013). Human papillomavirus: the fundamentals of HPV for oral health care providers. J Calif Dent Assoc, 41, 349-55.
|
9 |
Diamantopoulou S, Spathis A, Chranioti A, et al (2013). Liquid based cytology and HPV DNA testing in a Greek population compared to colposcopy and histology. Clin Exp Obstet Gynecol, 40, 131-6.
|
10 |
Didelot-Rousseau M, Courgnaud V, Nagot N, et al (2006). Comparison of INNO-LiPA HPV genotyping v2 with PCR product subcloning and sequencing for identification of genital human papillomavirus genotypes in African women. J Virol Methods, 135, 181-5.
DOI
ScienceOn
|
11 |
Grce M, Grahovac B, Rukavina T, et al (2007). HPV testing for cervical cancer screening in Croatia. Coll Antropol, 31, 67-71.
|
12 |
Galan-Sanchez F, Hernandez M, Hernandez D, et al (2011). Performance of the new INNO-LiPA HPV extra to genotype human papillomavirus in cervical cell specimens. Acta Cytol, 55, 341-3.
DOI
ScienceOn
|
13 |
Jaberipour M, Samsami A, Sahraiian F, et al (2011). Elevation of HPV-18 and HPV-16 DNA in the plasma of patients with advanced cervical cancer. Asian Pac J Cancer Prev, 12, 163-7.
|
14 |
Gold M, Thomas M, Huh W, et al (2013). High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test. J Low Genit Tract Dis, 17, 51-7.
DOI
ScienceOn
|
15 |
Grace J, Narendhirakannan R (2011). Detection and genotyping of high-risk HPV and evaluation of anti-oxidant status in cervical carcinoma patients in Tamil Nadu State, India. Asian Pac J Cancer Prev, 12, 2689-95.
|
16 |
Huang Y, Lin M, Luo Z, et al (2013). Low prevalence of HPV in male sexual partners of HR-HPV infected females and low concordance of viral types in couples in Eastern Guangdong. Asian Pac J Cancer Prev, 14, 1755-60.
DOI
ScienceOn
|
17 |
Karimi M, Behtash N, Chiti Z, et al (2009). Cervical cancer and HPV vaccines in developing countries. Asian Pac J Cancer Prev, 10, 969-74.
|
18 |
Micalessi M, Boulet G, Vorsters A, et al (2013). A real-time PCR approach based on SPF10 primers and the INNO-LiPA HPV genotyping extra assay for the detection and typing of human papillomavirus. J Virol Methods, 187, 166-71.
DOI
ScienceOn
|
19 |
Mohabatkar H (2007). Prediction of epitopes and structural properties of Iranian HPV-16 E6 by bioinformatics methods. Asian Pac J Cancer Prev, 8, 602-6.
|
20 |
Nirchio V, Lipsi R, Fusilli S, et al (2008). HPV infection: comparison between morphological studies and molecular biology. Pathologica, 100, 149-55.
|
21 |
Shahramian I, Heidari Z, Mahmoudzadeh H, et al (2011). Prevalence of HPV infection and high risk HPV genotypes (16, 18) among monogamous and polygamous women, In Zabol, Iran. Iran J Public Health, 40, 113-21.
|
22 |
Norman I, Hjerpe A, Andersson S (2013). High-risk HPV L1 capsid protein as a marker of cervical intraepithelial neoplasia in high-risk HPV positive women with minor cytological abnormalities. Oncol Rep, 30, 695-700.
DOI
|
23 |
Palefsky J (2006). Biology of HPV in HIV infection. Adv Dent Res, 19, 99-105.
DOI
|
24 |
Samoylova E , Shaikhaiev G, Petrov S, et al (1995). HPV infection in cervical-cancer cases in Russia. Int J Cancer, 61, 337-41.
DOI
ScienceOn
|
25 |
Yahyapour Y, Shamsi-Shahrabadi M, Mahmoudi M, et al (2012). High risk and low risk human papillomavirus in esophageal squamous cell carcinoma at Mazandaran northern Iran. Pathol Oncol Res, 21, 54-8.
|
26 |
Young A, Crosby R, Jagger K, et al (2010). HPV vaccine acceptability among women in the philippines. Asian Pac J Cancer Prev, 11, 1781-7.
|
27 |
Zandi K, Eghbali S, Hamkar R, et al (2010). Prevalence of various human papillomavirus genotypes among women who subjected to routine Pap smear test in Bushehr city. Virol J, 7, 65.
DOI
ScienceOn
|
28 |
Safaei A, Khanlari M, Momtahen M, et al (2010). Prevalence of high risk human papillomavirus types 16 and 18 in healthy women with cytologically negative pap smear in Iran. Indian J Pathol Microbiol, 53, 681-5.
DOI
ScienceOn
|